The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(4-chlorophenyl)-N-{4-[2-(morpholin-4-yl)ethyl]phenyl}-4-oxo-3,4-dihydrophthalazine-1-carboxamide ID: ALA5189718
PubChem CID: 163322235
Max Phase: Preclinical
Molecular Formula: C27H25ClN4O3
Molecular Weight: 488.98
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1ccc(CCN2CCOCC2)cc1)c1nn(-c2ccc(Cl)cc2)c(=O)c2ccccc12
Standard InChI: InChI=1S/C27H25ClN4O3/c28-20-7-11-22(12-8-20)32-27(34)24-4-2-1-3-23(24)25(30-32)26(33)29-21-9-5-19(6-10-21)13-14-31-15-17-35-18-16-31/h1-12H,13-18H2,(H,29,33)
Standard InChI Key: XFURMSAITSZFAY-UHFFFAOYSA-N
Molfile:
RDKit 2D
35 39 0 0 0 0 0 0 0 0999 V2000
-2.8559 -2.6812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1413 -2.2689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4294 -2.6808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4294 -3.5060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1395 -3.9178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8559 -3.5097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7147 -2.2682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0002 -2.6808 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0002 -3.5060 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7147 -3.9186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7147 -4.7438 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7144 -3.9186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4292 -3.5062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1413 -3.9182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1413 -4.7436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4310 -5.1556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7144 -4.7473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8559 -5.1562 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-0.7147 -1.4430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4294 -1.0304 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.0002 -1.0304 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0002 -0.2052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7147 0.2075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7139 1.0302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0008 1.4429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7127 1.0337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7175 0.2090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0008 2.2681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7137 2.6807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7137 3.5059 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.4284 3.9185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4284 4.7436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7137 5.1562 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0008 4.7436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0008 3.9185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
3 7 1 0
8 7 2 0
9 8 1 0
10 9 1 0
4 10 1 0
10 11 2 0
9 12 1 0
13 12 2 0
14 13 1 0
15 14 2 0
16 15 1 0
17 16 2 0
12 17 1 0
15 18 1 0
7 19 1 0
19 20 2 0
19 21 1 0
21 22 1 0
23 22 2 0
24 23 1 0
25 24 2 0
26 25 1 0
27 26 2 0
22 27 1 0
25 28 1 0
28 29 1 0
29 30 1 0
31 30 1 0
32 31 1 0
33 32 1 0
34 33 1 0
35 34 1 0
30 35 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 488.98Molecular Weight (Monoisotopic): 488.1615AlogP: 4.17#Rotatable Bonds: 6Polar Surface Area: 76.46Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.75CX Basic pKa: 7.24CX LogP: 4.73CX LogD: 4.50Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.44Np Likeness Score: -1.87
References 1. Shi W, Zhang P, Zou F, Zhou J, Yin Z, Cai Z, Ghaleb H, Jiang Y, Huang W, Liu Y, Qiu Q, Qian H.. (2022) Exploration of novel phthalazinone derivatives as potential efflux transporter inhibitors for reversing multidrug resistance and improving the oral absorption of paclitaxel., 233 [PMID:35247755 ] [10.1016/j.ejmech.2022.114231 ]